{{Rsnum
|rsid=2336219
|Gene=CD3EAP
|Chromosome=19
|position=45409148
|Orientation=plus
|GMAF=0.2576
|Gene_s=CD3EAP,ERCC1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.8 | 23.0 | 75.2
| HCB | 19.0 | 47.4 | 33.6
| JPT | 23.9 | 54.0 | 22.1
| YRI | 3.4 | 42.9 | 53.7
| ASW | 8.8 | 38.6 | 52.6
| CHB | 19.0 | 47.4 | 33.6
| CHD | 18.3 | 49.5 | 32.1
| GIH | 6.9 | 34.7 | 58.4
| LWK | 5.5 | 44.5 | 50.0
| MEX | 1.7 | 43.1 | 55.2
| MKK | 1.9 | 35.3 | 62.8
| TSI | 4.9 | 29.4 | 65.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=20061190
|Title=ERCC1 haplotypes modify bladder cancer risk: A case-control study
}}

{{GET Evidence
|gene=CD3EAP
|aa_change=Asp394Asn
|aa_change_short=D394N
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2336219
|overall_frequency_n=1830
|overall_frequency_d=10722
|overall_frequency=0.170677
|n_genomes=23
|n_genomes_annotated=0
|n_haplomes=28
|n_articles=0
|n_articles_annotated=0
|nblosum100=-1
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}